I don't know the particular details of the CanSino vaccine. I know that there were results published of the phase I trial, I believe, in The Lancet roughly two weeks ago.
I think the systemic global issue you're pointing to is the fact that we need more transparency and open reporting of data for all medical innovations. That's not a comment about this particular vaccine, but a comment on the broader global research and development architecture and system. We need to ensure that there is a responsibility to transparently report and share, I would say, clinical trials data—